News

Pfizer and Basilea Pharmaceutica announced that they have entered into an agreement whereby Pfizer will be granted the exclusive commercialization rights in Europe to CRESEMBA…
Read More...

Generon Corporation announced the initiation of a clinical trial for A-337, a CD3-activating bi-specific antibody targeting EpCAM, in Australia. This is a “Phase I, Open-label,…
Read More...

LEO Pharma today announced that the first patients have been dosed in a phase 3 clinical study of tralokinumab. Tralokinumab is an investigational human monoclonal antibody that…
Read More...

SGS announced that it has significantly increased its capabilities to undertake extractables and leachables (E&L) testing at its Shanghai, China, laboratory. Its investment…
Read More...

JSR Life Sciences (JLS) announced that JSR Corporation has agreed to acquire Selexis SA, a pioneering life sciences company and global leader in mammalian (suspension-adapted CHO-K1)…
Read More...

Axcella announced that Tony Tramontin, Ph.D., has joined the company as Chief Scientific Officer and Senior Vice President of Research & Development. Dr. Tramontin comes to Axcella…
Read More...

Arena Pharmaceuticals announced the appointment of Jennifer Jarrett to the Company's Board of Directors.  Ms. Jarrett has over 20 years of experience as a senior executive and finance…
Read More...

A certain group of genetic faults could be used to help predict if immunotherapy will work in cancer patients, according to a new US study. The research from John Hopkins…
Read More...

Pfizer Inc. and Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for tanezumab for the treatment of chronic pain in…
Read More...

Numab Therapeutics AG announced a collaboration and option agreement with Kaken Pharmaceutical Co., Ltd. for the identification of a multispecific antibody candidate for development in…
Read More...

Sanofi and Regeneron Pharmaceuticals, Inc. announced positive results from two Phase 3b/4 ODYSSEY-DM trials in patients with diabetes. In the studies, Praluent® (alirocumab), when…
Read More...

Eurofins Scientific announces the acquisition of Alphora Research Inc., a full service contract research, development and manufacturing organization (CRDMO) for complex and niche small…
Read More...

Numerate, Inc., a computational drug design company applying artificial intelligence (AI) at cloud scale to transform small molecule drug discovery, announced the formation of a…
Read More...

Selexis SA and TeneoBio announced that they have entered into a service agreement to advance the development of a new class of biologics, Human Heavy-Chain Antibodies (UniAbs) targeting…
Read More...

Midatech Pharma announced that it has signed a global licensing agreement with Novartis for the oncology compound panobinostat. Panobinostat will be developed by Midatech for the…
Read More...

Australian researchers have found a new way to use immunotherapy, a breakthrough mode of cancer treatment which harnesses the patient’s immune system, to treat an aggressive form of…
Read More...

Kleo Pharmaceuticals announced the appointment of Douglas J. Manion, M.D. FRCP(C) as Chief Executive Officer, effective immediately. Dr. David Spiegel M.D., Ph.D., co-founder of Kleo,…
Read More...

Olon S.p.A. announced the acquisition of Ricerca Biosciences' Chemical Division of the contract research (CRO) and CDMO based in Concord, Ohio, USA. This acquisition strengthens the…
Read More...

Tekni-Plex, Inc. is announcing a $15 million investment in a new state-of-the-art manufacturing facility in Suzhou, China, near Shanghai. It represents the single largest recent…
Read More...

Dr. Jonathan Goldman, CEO, Aptuit LLC, announced a strategic provider relationship between Aptuit, a leading Partnership Research Organization, and Regulus Therapeutics Inc, an…
Read More...